Entia: hand-held blood-testing lab for cancer care patients
Monitoring technology takes just a finger prick to carry out a blood test count that helps chemotherapy patients to manage their treatment.
A London-based healthtech start-up has developed a hand-held blood testing kit that can be used at home by chemotherapy patients to tailor treatment to their specific needs.
Entia’s Affinity™ monitor can reduce cancellations for chemotherapy appointments and limit hospital visits just for blood count checks. And that means there are more chemotherapy slots for other people awaiting urgent treatment.
Miniaturised optical technology
It will be another 2 years before the system can be fully operational and implemented commercially but their collaboration has already been short-listed for the AXA PPP Health Tech & You Challenge awards. Toby Basey-Fisher, CEO of Entia, said:
The involvement of The Royal Marsden Hospital as one of the world’s leading cancer care centres has been absolutely critical. Having them on board has been a huge benefit.
The project allows Entia to validate its miniaturised optical technology through laboratory and user testing and generate cost-effectiveness data to support the case for commercial adoption.
It should also prove that an established cloud-based framework can be used to transfer patient data to the clinic’s electronic health records.
Chemotherapy often reduces blood cell counts, exposing patients to infections, anaemia and other problems. Low blood counts, when discovered, are also the major cause of delayed treatment or reduced treatment dosage, as Toby explained:
The normal procedure has been for a patient to turn up at the hospital and take a blood test before undergoing treatment. But in 20% of cases they were being sent home because their blood counts were too low.
Our system is able to provide an accurate indication before they leave home that they are not ready to receive chemotherapy treatment. They can then reschedule and the appointment can be allocated to somebody else.
Using Affinity not only ensures that clinical pathways are fashioned around the individual’s needs but it also achieves a significant reduction in healthcare spending.
It is designed with built-in connectivity so that the individual, who may be elderly and very ill, does not have to worry about sharing information with health workers.
Improved quality of care
As a member of the Microsoft Accelerator programme Entia has access to world-leading support to create and enhance the cloud infrastructure that is critical to simplifying the patient’s treatment. Toby added:
We have as many designers as we have software and hardware engineers, because we believe that human-centred design must be at the centre of product development.
All the patient has to do is give a tiny sample of blood and the system takes care of everything else.
It is a very simple, elegant intervention that can have a huge impact on the quality of patients’ lives. Our solution not only improves quality of care but also promotes cost-effective treatment.
There are likely to be many other applications, and not just in cancer care, because blood counts are so widely used in hospitals and GP practices.
The only reason we are here is because of Innovate UK. The funding and support has been absolutely fantastic. I’d like to think we are a good example of why government investment in early-stage companies is so important.
Latest News from
Innovative ideas to change the world: new business funding19/02/2019 09:10:00
Innovate UK Smart funding launches with £20 million grant competition for ambitious projects that could disrupt a global industry or market.
Artificial intelligence to tackle insurance fraud and assess flood damage18/02/2019 08:10:00
40 artificial intelligence and data analytics projects announced to boost productivity and improve customer service.
Innovation in UK aerospace: funding for projects12/02/2019 15:20:00
Organisations are invited to submit ideas that promote competition and innovation in the UK aerospace industry.
Cyber security: funding to take academic ideas to market11/02/2019 12:20:00
Researchers based in UK academic institutions can apply for a share of up to £800,000 to support them in commercialising cyber security innovation.
UK-Canada collaborations to boost productivity: apply for funding07/02/2019 13:20:00
UK businesses can apply for a share of £5 million to work with Canadian partners on highly-innovative productivity projects that target global markets.
Resilient technologies to improve UK railways: apply for funding07/02/2019 09:10:00
Organisations can apply for a share of £5.5 million to integrate proven technologies into the UK rail industry.
AI and digital design to transform future of UK construction06/02/2019 13:25:00
£18 million Industrial Strategy Challenge Fund investment in research and innovation projects will transform how the UK delivers buildings and infrastructure.
Tackling productivity problems in UK industry: apply for funding06/02/2019 10:10:00
A share of £4 million is available for businesses to connect with the UK’s best scientists and facilities to improve productivity and competitiveness.